Neurology Archives - Page 5 of 10

Understanding the disease course and therapeutic benefit of tafamidis across real-world studies of hereditary transthyretin amyloidosis with polyneuropathy: a proof of concept for integrative data analytic approaches

Authors: D Serrano, C B Atzinger, M F Botteman Published: Neurology and Therapy, 2018 View publication Introduction Hereditary transthyretin (TTR) amyloidosis with polyneuropathy (hATTR-PN) is a rare, autosomal dominant amyloidosis characterized primarily...

The UK patient experience of relapse in Multiple Sclerosis treated with first disease modifying therapies

Authors: M Duddy, M Lee, O Pearson, E Nikfekr, A Chaudhuri, F Percival, M Roberts, C Whitlock Published: Multiple Sclerosis and Related Disorders, 2014 View publication Background The fixed, progressive disability associated...

Prediagnosis pathway benchmarking audit in patients with Duchenne Muscular Dystrophy

Authors: V L Gowda, M Fernandez, M Prasad, A-M Childs, I Hughes, S Tirupathi, C G E L De Goede, D O'Rourke, D Parasuraman, T Willis, S Saberian, I Davidson Published: Archives...

Emergency medicine physicians’ perspectives on diagnostic accuracy in neurology: a qualitative study

Authors: A L Liberman, N T Cheng, B W Friedman, M T Gerstein, K Moncrieffe, D L Labovitz, R B Lipton Published: Diagnosis, 2021 View publication Objectives We sought to understand the...

An innovative approach to modelling the optimal treatment sequence for patients with relapsing–remitting multiple sclerosis: implementation, validation, and impact of the decision-making approach

Authors: M A Piena, S Kroep, C Simons, E Fenwick, G H Harty, S L Wong, B A Van Hout Published: Advances in Therapy, 2021 View publication Introduction An innovative computational model...

A multicenter, randomized, double-blind, placebo-controlled study of the efficacy, tolerability, and safety of celecoxib oral solution (ELYXYB) in acute treatment of episodic migraine with or without aura

Authors: R B Lipton, S Munjal, S J Tepper, C Iaconangelo, D Serrano Published: Journal of Pain Research, 2021 View publication Background Safe, effective, oral therapies are needed for acute treatment of...

Changes in healthcare resource use and costs in commercially insured insomnia patients initiating Suvorexant

Authors: H P Kale, Z P Qureshi, R Shah, R l Khandker, M Botteman, W Meng, R Benca Published: Advances in Therapy, 2021 View publication Introduction Insomnia diagnosis has been associated with...

An integrated pharmacokinetic-pharmacodynamic-pharmacoeconomic modeling method to evaluate treatments for adults with schizophrenia

Authors: M A Piena, N Houwing, C W Kraan, X Wang, H Waters, R A Duffy, S Mallikaarjun, C Bennison Published: PharmacoEconomics, 2021 View publication Introduction Schizophrenia is a chronic mental disorder...

A three month interim analysis of quality of life in patients with relapsing remitting multiple sclerosis in the UK: the patient reported outcomes with fingolimod in local experience (PROFILE) study

Authors: Nick Adlard, Fiona Brisbane, Jane Watson, Catherine Bottomley, Michel Kroes Published: 2017 View publication

News